Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Fimmers

Showing results (261-270 of 280) with videos related to

Pageof 28
Sort By:
Neurology|September 29, 2020
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphomaSabine Seidel, Hendrik Pels, Sabine Schlömer, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 16, 2018
Characterization of Severe Arterial Phase Respiratory Motion Artifact on Gadoxetate Disodium-Enhanced MRI - Assessment of Interrater Agreement and ReliabilityKristina Imeen Ringe, Julian A Luetkens, Rolf Fimmers, et al.
Journal of the American Heart Association|July 21, 2016
Comprehensive Cardiac Magnetic Resonance for Short-Term Follow-Up in Acute MyocarditisJulian A Luetkens, Rami Homsi, Darius Dabir, et al.
Medicine|May 20, 2016
γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative NeoplasmJan Görtzen, Lena M Hunka, Maria Vonnahme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2019
Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical TrialLinda Batsa Debrah, Ute Klarmann-Schulz, Jubin Osei-Mensah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2013
Anticancer effects of niclosamide in human glioblastomaAnja Wieland, Daniel Trageser, Sabine Gogolok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2003
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapyHendrik Pels, Ingo G H Schmidt-Wolf, Axel Glasmacher, et al.
Stem Cells (Dayton, Ohio)|February 8, 2013
Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastomaMartin Glas, Christoph Coch, Daniel Trageser, et al.
Annals of Neurology|March 13, 2010
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphomaAnnika Juergens, Hendrik Pels, Sabine Rogowski, et al.
Journal of Neuro-Oncology|October 22, 2008
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyHendrik Pels, Annika Juergens, Axel Glasmacher, et al.
Pageof 28

Showing results (261-270 of 280) with videos related to

Sort By:
Pageof 28
Neurology|September 29, 2020
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphomaSabine Seidel, Hendrik Pels, Sabine Schlömer, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 16, 2018
Characterization of Severe Arterial Phase Respiratory Motion Artifact on Gadoxetate Disodium-Enhanced MRI - Assessment of Interrater Agreement and ReliabilityKristina Imeen Ringe, Julian A Luetkens, Rolf Fimmers, et al.
Journal of the American Heart Association|July 21, 2016
Comprehensive Cardiac Magnetic Resonance for Short-Term Follow-Up in Acute MyocarditisJulian A Luetkens, Rami Homsi, Darius Dabir, et al.
Medicine|May 20, 2016
γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative NeoplasmJan Görtzen, Lena M Hunka, Maria Vonnahme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2019
Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical TrialLinda Batsa Debrah, Ute Klarmann-Schulz, Jubin Osei-Mensah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2013
Anticancer effects of niclosamide in human glioblastomaAnja Wieland, Daniel Trageser, Sabine Gogolok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2003
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapyHendrik Pels, Ingo G H Schmidt-Wolf, Axel Glasmacher, et al.
Stem Cells (Dayton, Ohio)|February 8, 2013
Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastomaMartin Glas, Christoph Coch, Daniel Trageser, et al.
Annals of Neurology|March 13, 2010
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphomaAnnika Juergens, Hendrik Pels, Sabine Rogowski, et al.
Journal of Neuro-Oncology|October 22, 2008
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyHendrik Pels, Annika Juergens, Axel Glasmacher, et al.
Pageof 28